Eye on Neuromyelitis Optica Spectrum Disorder
Jointly Provided by
This activity was supported by an educational grant from Alexion Pharmaceuticals.
Start date: February 28, 2021
End date: February 28. 2022
NO LONGER AVAILABLE FOR CREDIT
Estimated time to complete: 0.50 hours
Activity Description
Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune disease often characterized by sporadic and repeated inflammatory flare ups that can impact the optic nerve and/or spinal cord. With each repeated attack, additional permanent neurological damage will accrue. This CME activity highlights the important role both ophthalmologists and neurologists play in diagnosing and treating NMOSD most efficiently.
Activity Faculty
Michael Levy, MD, PhD
Associate Neurologist, Massachusetts General Hospital
Director, Neuromyelitis Optica Clinic and Research Laboratory
Research Director, Division of Neuroimmunology & Neuroinfectious Disease
Prem Subramanian, MD, PhD
Professor, Ophthalmology
Chief, Neuro-Ophthalmology
University of Colorado Hospital
Target Audience
This activity has been designed to meet the educational needs of physicians specializing in Ophthalmology and Neurology. Other members of the team caring for patients with NMOSD may also participate.
Learning Objectives
After participating in the activity, learners should be better able to:
- Describe ophthalmologic signs and symptoms in a person suspected of having NMOSD in order to reduce the time to diagnosis.
Accreditation and Credit Designation
In support of improving patient care, this activity has been planned and implemented by American Academy of CME, Inc. and CheckRare CE. American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
American Academy of CME, Inc., designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Statement
According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity and levels of evidence.
Disclosures are as follows:
Michael Levy, MD, PhD
Advisory Board for scientific information – Alexion, Viela Bio, Genentech
Consultant for clinical trial design – Alexion, Viela Bio, Genentech, Mitsubishi Pharma, UCB Pharmaceuticals
Grant Recipient/Research Support– Alexion, Genentech
Prem Subramanian, MD, PhD
Advisory Board for scientific information- Horizon Therapeutics, Invex Therapeutics
Grant Recipient/Research Support– Horizon Therapeutics, GenSight Biologics, Santhera Pharmaceuticals
Planners for this activity have no relevant financial relationships with any commercial interests.
This activity will review off-label or investigational information.
The opinions expressed in this educational activity are those of the faculty, and do not represent those of the Academy or CheckRare CE. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information.
Method of Participation
There are no fees to participate in the activity. Participants must review the activity information including the learning objectives and disclosure statements, as well as the content of the activity. To receive CME credit for your participation, please complete the post-program assessment. Your certificate can be mailed to you in approximately 30 days.
Hardware/Software Requirements
Windows Requirements: • Operating system: Windows XP Service Pack 2 or later • Browser: Internet Explorer 7 or later, Mozilla Firefox 2.5 or later • Internet connection: DSL, cable modem, or other high-speed connection
Macintosh Requirements: • Operating system: Mac OS X v10.3 or later • Browser: Mozilla Firefox 2.5 or later • Internet connection: DSL, cable modem, or other high-speed connection
Privacy
For more information about the American Academy of CME privacy policy, please access http://www.academycme.org/privacy.htm. For more information about CheckRare’s privacy policy, please access https://checkrare.com/privacy/
Contact
For any questions, please contact: [email protected]
Copyright
© 2021. This CME-certified activity is held as copyrighted © by American Academy of CME and CheckRare CE. Through this notice, the Academy and CheckRare grant permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).
Eye on Neuromyelitis Optica Spectrum Disorder
Supplemental Video
Jointly Provided by
This activity was supported by an educational grant from Alexion Pharmaceuticals.
Start date: February 28, 2021
End date: February 28. 2022
NO LONGER AVAILABLE FOR CREDIT
Estimated time to complete: 0.50 hours
Activity Description
Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune disease often characterized by sporadic and repeated inflammatory flare ups that can impact the optic nerve and/or spinal cord. With each repeated attack, additional permanent neurological damage will accrue. This CME activity highlights the important role both ophthalmologists and neurologists play in diagnosing and treating NMOSD most efficiently.
Activity Faculty
Michael Levy, MD, PhD
Associate Neurologist, Massachusetts General Hospital
Director, Neuromyelitis Optica Clinic and Research Laboratory
Research Director, Division of Neuroimmunology & Neuroinfectious Disease
Prem Subramanian, MD, PhD
Professor, Ophthalmology
Chief, Neuro-Ophthalmology
University of Colorado Hospital
Target Audience
This activity has been designed to meet the educational needs of physicians specializing in Ophthalmology and Neurology. Other members of the team caring for patients with NMOSD may also participate.
Learning Objectives
After participating in the activity, learners should be better able to:
- Describe ophthalmologic signs and symptoms in a person suspected of having NMOSD in order to reduce the time to diagnosis.
Accreditation and Credit Designation
In support of improving patient care, this activity has been planned and implemented by American Academy of CME, Inc. and CheckRare CE. American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
American Academy of CME, Inc., designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Statement
According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity and levels of evidence.
Disclosures are as follows:
Michael Levy, MD, PhD
Advisory Board for scientific information - Alexion, Viela Bio, Genentech
Consultant for clinical trial design - Alexion, Viela Bio, Genentech, Mitsubishi Pharma, UCB Pharmaceuticals
Grant Recipient/Research Support– Alexion, Genentech
Prem Subramanian, MD, PhD
Advisory Board for scientific information- Horizon Therapeutics, Invex Therapeutics
Grant Recipient/Research Support– Horizon Therapeutics, GenSight Biologics, Santhera Pharmaceuticals
Planners for this activity have no relevant financial relationships with any commercial interests.
This activity will review off-label or investigational information.
The opinions expressed in this educational activity are those of the faculty, and do not represent those of the Academy or CheckRare CE. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information.
Method of Participation
There are no fees to participate in the activity. Participants must review the activity information including the learning objectives and disclosure statements, as well as the content of the activity. To receive CME credit for your participation, please complete the post-program assessment. Your certificate can be mailed to you in approximately 30 days.
Hardware/Software Requirements
Windows Requirements: • Operating system: Windows XP Service Pack 2 or later • Browser: Internet Explorer 7 or later, Mozilla Firefox 2.5 or later • Internet connection: DSL, cable modem, or other high-speed connection
Macintosh Requirements: • Operating system: Mac OS X v10.3 or later • Browser: Mozilla Firefox 2.5 or later • Internet connection: DSL, cable modem, or other high-speed connection
Privacy
For more information about the American Academy of CME privacy policy, please access http://www.academycme.org/privacy.htm. For more information about CheckRare's privacy policy, please access https://checkrare.com/privacy/
Contact
For any questions, please contact: [email protected]
Copyright
© 2021. This CME-certified activity is held as copyrighted © by American Academy of CME and CheckRare CE. Through this notice, the Academy and CheckRare grant permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).
